跳至主要内容
临床试验/IRCT2013082914521N1
IRCT2013082914521N1已完成2 期

Investigation of the effects of supplementation with curcuminoids on on cardiovascular risk factors in obese dyslipidemic subjects

Mashhad University of Medical Sciences Research Council0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • obese subjects (with body mass index (BMI) = 30) who had either < 2 risk factors (except diabetes mellitus) for coronary heart disease (CHD) plus 160 mg/dL < LDL-C < 190 mg/dL, or = 2 CHD risk factors (except diabetes mellitus) and 130 mg/dL < LDL-C < 160 mg/dL. Exclusion criteria were history of systemic diseases (such as systemic lupus erythematosus, kidney disease, diabetes mellitus and established cardiovascular disease), consumption of drug supplements within the preceding 6 months and history of taking any lipid-lowering drug.
  • Exclusion criteria: systemic disease or history of systemic disease (such as lupus, kidney disease, diabetes mellitus); history of cardiovascular disease; BMI < 30; consumption of drug supplements within the 6 months and history of taking any lipid lowering drug.

排除标准

  • 未提供

研究者

发起方
Mashhad University of Medical Sciences Research Council

相似试验